Diagnostic accuracy for neurodegenerative conditions has not significantly improved in the last 30 year, often relying on the experience and perception of highly-qualified neurologists rather than quantitative measures with precise clinical thresholds. machineMD is rapidly innovating to bring new digital health solutions that will improve diagnostic and disease monitoring capabilities, which are prerequisites for the development of early-stage therapeutics.

User-Centred HealthTech is a National Thematic Network fostering focus on the users of medical devices in early phases of development with the goal to speed up successful market introduction of promising medical products. The 2022 call for applications has resulted in the award of 5 grants, with a total of CHF 80’000 to boost innovation with new and disruptive ideas including machineMD’s project.  

The expert panel highlighted the collaboration between machineMD and Inselspital as being a uniquely outstanding combination of technical and clinical expertise, with a high degree of user centricity and potential for developing radically innovative solutions.  

“User-centric design is a cornerstone of our research and development,” explained Samuel Schenk, Head of R&D at machineMD. “Our winning combination of technical expertise and clinical collaboration with Inselspital continues to drive innovation that will directly benefit patient diagnosis.”

User-Centred HealthTech is formed of the Eastern Switzerland University of Applied Sciences (Ostschweizer Fachhochschule), Health Tech Cluster Switzerland, Swiss Institute for Translational and Entrepreneurial Medicine (SITEM-Insel), University of Bern, Bern University of Applied Sciences (Berner Fachhochschlue), and Switzerland Innovation Park Biel/Bienne. The Innovation Booster program is powered by Innosuisse.